Universal Detection's Director of Research Discusses Bio-Threat Detection Device in Debut Interview on HomelandInsights.com

Novel Counterterrorism Solution Continuously Samples and Analyzes Airborne Threats Using Integrated NASA Technology

LOS ANGELES, Oct. 10, 2005 (PRIMEZONE) -- HomelandInsights.com, the online source for expert information on high-growth investing in the Homeland Security marketplace, today announced the availability of an exclusive audio interview with Los Angeles-based Universal Detection Technology (OTCBB:UDTT), (FWB:PO8), an innovator of monitoring systems to detect biological threats in the global war on terror.

In the interview, Amir Ettehadieh, UDTT's Director of Research and Development, provides an overview of the technology behind the Company's continuous monitoring system for the detection of dangerous airborne biological threats such as anthrax spores. The Company's initial product integrates spore detection technology developed by NASA's Jet Propulsion Lab for use in space exploration, with its own proprietary "aerosol capture" technology, Mr. Ettehadieh said. The technology could improve the monitoring of leading biological threats, including anthrax. Its premiere application to detect anthrax spores is being further developed for commercialization in the near future, under the name BSM-2000.

UDTT has designed the BSM-2000 as an early-warning anthrax detection device that can alert to the presence of anthrax spores, in the period bioterrorism experts refer to as the "detect-to-treat" time frame. This is the period when early commencement of safety measures, such as evacuation and medical treatment, can provide the greatest level of protection and save the most lives. Anthrax has been named one of the gravest of biological dangers by such authorities as former CIA director George Tenet. One expert study estimated that a release of just two pounds of weapons grade anthrax could result in more than 100,000 deaths; homeland security authorities have said early warning of such biological attacks is one of the most important factors in protecting the public.

This is Universal Detection Technology's premiere interview on HomelandInsights.com. The interview can be accessed free of charge by visiting: http://www.HomelandInsights.com.

Compensation and Other Disclosures

HomelandInsights.com is a wholly-owned subsidiary of Trilogy Capital Partners, Inc. Trilogy Capital Partners provides investor relations services to public companies. The companies presented by HomelandInsights.com are usually clients of Trilogy Capital Partners and compensate Trilogy Capital Partners for these services, including cash compensation and equity securities. In addition, Trilogy Capital Partners and its affiliates may own securities of the presenting companies, and may from time to time purchase and sell securities of these companies in the open market or in private transactions. UDTT is contracted to pay Trilogy $12,500 per month through August 2006 and thereafter for so long as Trilogy is retained to provide investor relations services. In connection with its engagement, Trilogy received non-transferable warrants from this company to purchase 3,600,000 shares of common stock for $0.17 per share expiring in August 2008, provided that the warrants are not exercisable to the extent that following exercise Trilogy would beneficially own 5% or more of the outstanding common stock of the company.

About Universal Detection Technology

Universal Detection Technology (UDTT), founded in 1973, is a developer of advanced monitoring and early-warning technologies whose mission is to help meet today's heightened security and defense requirements in the global war on terror. The Company's intellectual property portfolio includes exclusive worldwide commercial licensing of technology developed by NASA's Jet Propulsion Laboratory (JPL) and its own proprietary aerosol capture technology, which are combined in the Company's initial monitoring device, the BSM-2000. Management believes that the Company's technology, together with third party technologies and devices, has positioned it to capitalize on growth and value opportunities related to Homeland Security. For more information, please visit http://udtt.invrel.net or http://www.udetection.com. To view investor-specific information about the Company, including recent news and other data, please visit http://www.trilogy-capital.com/tcp/udt. To read or download an Investor Fact Sheet about the Company, please visit http://www.trilogy-capital.com/tcp/udt/factsheet.html. Universal Detection Technologies is also listed on the Frankfurt Stock Exchange under the ticker symbol PO8.

About HomelandInsights.com

HomelandInsights.com provides exclusive commentary, research, interviews and other information focused on the fast-growing global homeland security marketplace. The primary mission of HomelandInsights.com is to provide informed investors with information and commentary about investment growth opportunities within the homeland security industry. Resources available on HomelandInsights.com include audio interviews with corporate leaders and respected commentators, as well as technical white papers and other forms of market and investment analysis. It is located at http://www.HomelandInsights.com.

Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt, our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market, our ability to commercially produce our products on a profitable basis, commercial acceptance of our products, product price volatility, product demand, market competition and general economic conditions, and other factors described in the Company's filings with the Securities and Exchange Commission. We undertake no obligation and do not intend to revise or update publicly any forward looking statements for any reason.


Contact Data